The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation.

R Lewis; A M Bagnall; S King; N Woolacott; C Forbes; L Shirran; S Duffy; J Kleijnen; G ter Riet; R Riemsma

The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation.

R Lewis, A M Bagnall, S King, N Woolacott, C Forbes, L Shirran, S Duffy, J Kleijnen, G ter Riet, R Riemsma

Centre for Reviews and Dissemination

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-269
Number of pages	269
Journal	Health Technology Assessment
Volume	6(14):
Publication status	Published - 2002

Access to Document

http://www.hta.ac.uk/fullmono/mon614.pdf

Cite this

@article{662f9129dd4d4f1b8a91628cb3fce56a,

title = "The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation.",

author = "R Lewis and Bagnall, {A M} and S King and N Woolacott and C Forbes and L Shirran and S Duffy and J Kleijnen and {ter Riet}, G and R Riemsma",

year = "2002",

language = "English",

volume = "6(14):",

pages = "1--269",

journal = "Health Technology Assessment",

issn = "2046-4924",

publisher = "NHS National Institute for Health Research",

}

TY - JOUR

T1 - The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation.

AU - Lewis, R

AU - Bagnall, A M

AU - King, S

AU - Woolacott, N

AU - Forbes, C

AU - Shirran, L

AU - Duffy, S

AU - Kleijnen, J

AU - ter Riet, G

AU - Riemsma, R

PY - 2002

Y1 - 2002

M3 - Article

SN - 2046-4924

VL - 6(14):

SP - 1

EP - 269

JO - Health Technology Assessment

JF - Health Technology Assessment

ER -